BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21161652)

  • 1. Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer: results of a randomized controlled trial.
    Imamura H; Kurokawa Y; Kawada J; Tsujinaka T; Takiguchi S; Fujiwara Y; Mori M; Doki Y
    World J Surg; 2011 Mar; 35(3):625-30. PubMed ID: 21161652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bursectomy Versus Nonbursectomy for Gastric Adenocarcinoma: A Single-Center, Propensity-Score Matched Cohort Study in China.
    Hu Z; Li Y; Zhang J; Chen B; Meng X
    J Laparoendosc Adv Surg Tech A; 2020 Apr; 30(4):389-394. PubMed ID: 31928499
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial.
    Fujita J; Kurokawa Y; Sugimoto T; Miyashiro I; Iijima S; Kimura Y; Takiguchi S; Fujiwara Y; Mori M; Doki Y
    Gastric Cancer; 2012 Jan; 15(1):42-8. PubMed ID: 21573917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.
    Sano T; Sasako M; Yamamoto S; Nashimoto A; Kurita A; Hiratsuka M; Tsujinaka T; Kinoshita T; Arai K; Yamamura Y; Okajima K
    J Clin Oncol; 2004 Jul; 22(14):2767-73. PubMed ID: 15199090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes after prophylactic bursectomy in patients with resectable gastric cancer: Final analysis of a multicenter randomized controlled trial.
    Hirao M; Kurokawa Y; Fujita J; Imamura H; Fujiwara Y; Kimura Y; Takiguchi S; Mori M; Doki Y;
    Surgery; 2015 Jun; 157(6):1099-105. PubMed ID: 25704429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial.
    Kurokawa Y; Doki Y; Mizusawa J; Terashima M; Katai H; Yoshikawa T; Kimura Y; Takiguchi S; Nishida Y; Fukushima N; Iwasaki Y; Kaji M; Hirao M; Katayama H; Sasako M
    Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):460-468. PubMed ID: 29709558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D2 gastrectomy with versus without bursectomy for gastric cancer.
    Kochi M; Fujii M; Kanamori N; Kaiga T; Mihara Y; Funada T; Tamegai H; Takayama Y; Yoshida N; Takayama T
    Am J Clin Oncol; 2014 Jun; 37(3):222-6. PubMed ID: 22892432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Totally laparoscopic complete bursectomy and D2 lymphadenectomy in radical total gastrectomy: an outside bursa omentalis approach.
    Zou L; Xiong W; Mo D; Chen G; He Y; Li H; Tan P; Wang W; Wan J
    Surg Endosc; 2016 Sep; 30(9):4152. PubMed ID: 26675932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of bursectomy in patients with resectable gastric cancer: An updated meta-analysis.
    Xiong B; Ma L; Huang W; Cheng Y; Luo H; Wang K
    Eur J Surg Oncol; 2019 Aug; 45(8):1483-1492. PubMed ID: 30691723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons.
    Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
    Hepatogastroenterology; 2006; 53(69):389-94. PubMed ID: 16795979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.
    Hu Y; Huang C; Sun Y; Su X; Cao H; Hu J; Xue Y; Suo J; Tao K; He X; Wei H; Ying M; Hu W; Du X; Chen P; Liu H; Zheng C; Liu F; Yu J; Li Z; Zhao G; Chen X; Wang K; Li P; Xing J; Li G
    J Clin Oncol; 2016 Apr; 34(12):1350-7. PubMed ID: 26903580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bursectomy and non-bursectomy D2 gastrectomy for advanced gastric cancer, initial experience from a single institution in China.
    Zhang WH; Chen XZ; Yang K; Liu K; Chen ZX; Zhang B; Zhou ZG; Hu JK
    World J Surg Oncol; 2015 Dec; 13():332. PubMed ID: 26643472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of bursectomy after radical gastrectomy for gastric cancer.
    Kayaalp C; Piskin T; Olmez A
    World J Surg; 2012 Jan; 36(1):229; author reply 230. PubMed ID: 21833663
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastrectomy and lymphadenectomy for gastric cancer: is the pancreas safe?
    Herbella FA; Tineli AC; Wilson JL; Del Grande JC
    J Gastrointest Surg; 2008 Nov; 12(11):1912-4. PubMed ID: 18612707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
    Memon MA; Subramanya MS; Khan S; Hossain MB; Osland E; Memon B
    Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is bursectomy necessary for patients with gastric cancer invading the serosa?
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Hasegawa S; Ishiwa N; Morinaga S; Noguchi Y; Yamamoto Y; Matsumoto A
    Hepatogastroenterology; 2004; 51(59):1524-6. PubMed ID: 15362792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.
    Cuschieri A; Fayers P; Fielding J; Craven J; Bancewicz J; Joypaul V; Cook P
    Lancet; 1996 Apr; 347(9007):995-9. PubMed ID: 8606613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
    Danielson H; Kokkola A; Kiviluoto T; Sirén J; Louhimo J; Kivilaakso E; Puolakkainen P
    Scand J Surg; 2007; 96(1):35-40. PubMed ID: 17461310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.
    Degiuli M; Sasako M; Ponti A; Calvo F
    Br J Cancer; 2004 May; 90(9):1727-32. PubMed ID: 15150592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.